Product
Oral Treprostinil
Aliases
Orenitram
Name
Orenitram
INN Name
treprostinil
FDA Approved
Yes
3 clinical trials
1 organization
2 indications
1 document
Indication
Pulmonary HypertensionIndication
Pulmonary Arterial HypertensionClinical trial
A 12-Week, International, Multicenter, Double-Blind, Randomized, Placebo-Controlled Comparison of the Efficacy and Safety of Oral UT-15C Sustained Release Tablets in Subjects With Pulmonary Arterial HypertensionStatus: Completed, Estimated PCD: 2011-04-01
Clinical trial
A Phase 4, Prospective, Multicenter, Single-Arm Study of a Mean Pulmonary Artery Pressure-Targeted Approach With Early and Rapid Treprostinil Therapy to Reverse Right Ventricular Remodeling in Patients With Pulmonary Arterial Hypertension: ARTISAN (Afterload Reduction To Improve Right Ventricular Structure And FuNction)Status: Recruiting, Estimated PCD: 2024-09-12
Clinical trial
ADAPT - A Patient Registry of the Real-world Use of Orenitram®Status: Active (not recruiting), Estimated PCD: 2022-04-07
Document
DailyMed Label: OrenitramOrganization
United Therapeutics Corporation